Exact Mass: 566.2026112
Exact Mass Matches: 566.2026112
Found 447 metabolites which its exact mass value is equals to given mass value 566.2026112,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
100-1
Jamaicamide A
Mulberroside F
Constituent of the leaves of Morus alba (white mulberry). Mulberroside F is found in fats and oils and herbs and spices. Mulberroside F is found in fats and oils. Mulberroside F is a constituent of the leaves of Morus alba (white mulberry).
5'-Hydroxycastavinol
5-Hydroxycastavinol is found in alcoholic beverages. 5-Hydroxycastavinol is isolated from a Bordeaux red win
Cassiaside B
Isolated from seeds of Cassia tora (charota). Cassiaside B is found in coffee and coffee products, herbs and spices, and pulses. Cassiaside B is found in coffee and coffee products. Cassiaside B is isolated from seeds of Cassia tora (charota).
3,4,5-trihydroxy-6-{4-[(E)-2-(3-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]phenoxy}oxane-2-carboxylic acid
3,4,5-trihydroxy-6-{4-[(e)-2-(3-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethenyl]phenoxy}oxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2-{3-hydroxy-5-[(e)-2-(4-hydroxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
3,4,5-trihydroxy-6-{3-[(E)-2-(4-hydroxyphenyl)ethenyl]-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy}oxane-2-carboxylic acid
3,4,5-trihydroxy-6-{3-[(e)-2-(4-hydroxyphenyl)ethenyl]-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy}oxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 2-{3-hydroxy-5-[(e)-2-(4-hydroxyphenyl)ethenyl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
N-[6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
PA(2:0/6 keto-PGF1alpha)
C25H43O12P (566.2492007999999)
PA(2:0/6 keto-PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/6 keto-PGF1alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(6 keto-PGF1alpha/2:0)
C25H43O12P (566.2492007999999)
PA(6 keto-PGF1alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(6 keto-PGF1alpha/2:0), in particular, consists of one chain of one 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(2:0/TXB2)
C25H43O12P (566.2492007999999)
PA(2:0/TXB2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/TXB2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(TXB2/2:0)
C25H43O12P (566.2492007999999)
PA(TXB2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(TXB2/2:0), in particular, consists of one chain of one Thromboxane B2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
MulberrosideF
Mulberroside F is a member of benzofurans. Mulberroside F is a natural product found in Morus alba with data available.
5,5-Dihydroxy-3,6,7,2,4-pentamethoxyflavone 5-glucoside
Chrysosplenoside H
4-Methoxy-3,3,5-trihydroxystilbene 3-O-beta-D-(2-O-p-coumaryl)-glucopyranoside
methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
(5S,6R,7R,8S)-2-(2-Phenylethyl)-5,6,7-tri-hydroxy-5,6,7,8-tetrahydro-8-[2-(2-phenylethyl)chromonyl-6-oxy]chromone (AH13)|(5S,6R,7R,8S)-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydro-8-<2-(2-phenylethyl)chromonyl-6-oxy>chromone|(5S,6R,7R,8S)-2-(2-phenylethyl)-5,6,7-trihydroxy-5,6,7,8-tetrahydro-8-[2-(2-phenylethyl)chromonyl-6-oxy]chromone|AH13
(1aR,1bS,2S,5aS,6S,6aS)-2-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-methyloxireno[4,5]cyclopenta[1,2-c]pyran-5-carboxylic acid methyl ester|6-O-beta-D-glucopyranosylphlorigidoside C
7-O-(alpha-L-Arabinosyl-beta-D-glucopyranoside)-(S)-4,5,7-Trihydroxyflavanone
1-O-[beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranosyl]-3,5-dimethoxyxanthone|3,5-Dimethoxy-1-O-primeverosylxanthone
(5S,6S,7S,8R)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-<2-(2-phenylethyl)chromonyl-6-oxy>chromone|(5S,6S,7S,8R)-2-(2-phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenylethyl)chromonyl-6-oxy]chromone|(5S,6S,7S,8R)-2-(2-Phenylethyl)-6,7,8-trihydroxy-5,6,7,8-tetrahydro-5-[2-(2-phenylethyl)chromonyl-6-oxy]chromone (AH14)|AH10
(1R,2S,4S,5S,6R,7S,8S,9R,10S)-1-acetoxy-9-benzoyloxy-8-trans-cinnamoyloxy-2,4,6-trihydroxydihydro-beta-agarofuran
6-O-[(E)-caffeoyl]deacetylasperuloside acid methyl ester|methyl (1S,4aS,5S,7aS)-1-[(6-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-beta-D-glucopyranosyl)oxy]-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylate
8-C-alpha-L-arabinopyranosyl-7-O-beta-D-glucopyranosylnaringenin
A glycosyloxyflavone and a flavone C-glycoside that is (S)-naringenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage and a alpha-L-arabinopyranosyl residue at position 8. It has been isolated from the roots and leaves of Petrorhagia velutina.
(rel)-(1R,4aS,8S,8aS)-8-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-4,4a,8,8a-tetrahydro-1-methyl-3-oxo-1H,3H-pyrano[3,4-c]pyran-5-carboxylic acid methyl ester|lamiuamplexoside B
naringenin 7-O-(2-beta-D-apiofuranosyl)-beta-D-glucopyranoside|naringenin-7-O-(2-O-beta-D-apiofuranosyl)-beta-D-glucopyranoside
(2R,3S,4S)-2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-4-[(4-hydroxy-3-methoxyphenyl)methyl]tetrahydrofuran 3-{[(2R)-2-carbomethoxy-2-hydroxy]ethyl}benzoate|hyosmin
Naringenin-4-O-beta-glucopyranosyl-alpha-xylopyranosid
10-demethylflavasperone-10-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside
(l(-)-tyrosyl)=>glutaminyl=>glutaminyl=>-glutamic acid|(l(-)-Tyrosyl)=>glutaminyl=>glutaminyl=>-glutaminsaeure
Eriodictyol 5-methyl ether 7-O-xylosyl-(1->4)-arabinoside
monodictyochromone A
A chromanone isolated from the marine derived fungus Monodictys putredinis and exhibits inhibitory activity against P450.
10-(6-O-trans-sinapoyl-beta-D-glucopyranosyl)gardendiol|11-(6-O-trans-sinapoyl-beta-glucopyranosyl)gardendiol
4-O-(beta-D-Xylopyranosyl-beta-D-glucopyranoside)--6-p-Coumaroylprunin-4,5,7-Trihydroxyflavanone
6-O-(5-O-p-coumaroyl)-beta-d-apiofuranosyl-beta-d-glucopyranoside|maltol 6-O-(5-O-p-coumaroyl)-(1->6)-beta-D-apiofranosyl-beta-D-glucopyranoside
12-O-butenoyl-5-hydroxy-6,7-epoxy-resiniferonol-9,13,14-orthobenzoate
pinobankasin-6-C-glucopyranosyl-8-C-arabinopyranoside
4-methoxy-9,10-dihydrophenanthrene-2,7-di-O-beta-D-glucopyranoside
(2E)-1-{2,4-dihydroxy-6-methoxy-3-[(2R,4S,6S)-tetrahydro-2-(4-hydroxyphenyl)-6-(2-phenylethyl)-2H-pyran-4-yl]phenyl}-3-(4-hydroxyphenyl)prop-2-en-1-one|Katsumain D
(2E)-1-{(2R,4S)-3,4-dihydro-5-hydroxy-4-[(2S)-2-hydroxy-4-(4-hydroxyphenyl)butyl]-2-(4-hydroxyphenyl)-7-methoxy-2H-1-benzopyran-6-yl}-3-phenylprop-2-en-1-one|katsumain E
2?-hydroxy-4?-methoxydibenzoyl-4?-O-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranoside|sophodibenzoside D
(2E)-1-{(2R,4S)-3,4-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4-[(2S)-2-hydroxy-4-phenylbutyl]-7-methoxy-2H-1-benzopyran-6-yl}-3-(4-hydroxyphenyl)prop-2-en-1-one|katsumain G
2?-hydroxy-4?-methoxydibenzoyl-4?-O-beta-D-apiofuranosyl-(1?6)-beta-D- glucopyranoside|sophodibenzoside E
(+)-lyoniresinol-3alpha-O-alpha-L-rhamonopyranoside
E-3-[3-(benzoyloxymethyl)-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydrobenzo[b]furan-5-yl]prop-2-enyl benzoate
(aS)-(5R,6S,7R,8R)-8-benozyloxy-5,6,7,8-tetrahydro-1,5-dihydroxy-3,12-dihydroxy-1,2,10,11-tetramethoxy-6,7-dimethyldibenzo[a,c]cycloocten-5-yl acetate|kadsuphilin I
6-O-[(6-O-allophanyl)-beta-D-glucopyranosyl]-5-hydroxy-2-methoxy-7-phenylphenalen-1-one
10-(6-O-trans-sinapoyl-beta-glucopyranosyl)gardendiol|11-(6-O-trans-sinapoyl-beta-D-glucopyranosyl)gardendiol
(8R*,7S*,8R*)-5,5-dimethoxy-7-oxolariciresinol 9-O-beta-D-xylopyranoside
5-methylresveratrol-3,4-O-beta-D-diglucopyranoside
monodictyochromone B
A chromanone isolated from the marine derived fungus Monodictys putredinis and exhibits inhibitory activity against P450.
Asn Tyr Arg Asp
Asn Tyr Asp Arg
3,6,7,2,4-pentamethylquercetagetin 3-O-beta-D-glucoside
CassiasideB
Cassiaside B is a natural product found in Senna obtusifolia with data available.
4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoic acid
(4S,5Z,6S)-5-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyethylidene]-4-(2-methoxy-2-oxoethyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
C23H34O16_beta-D-Glucopyranose, 1-[2-[(2S,3E,4S)-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetate]
(4S,5Z,6S)-5-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyethylidene]-4-(2-methoxy-2-oxoethyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
(4S,5Z,6S)-5-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyethylidene]-4-(2-methoxy-2-oxoethyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid [IIN-based: Match]
methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_major
methyl (4S,5E,6S)-5-ethylidene-4-[2-oxo-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate_98.3\\%
(4S,5Z,6S)-5-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyethylidene]-4-(2-methoxy-2-oxoethyl)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid_major
Ala Gln Trp Tyr
C28H34N6O7 (566.2488854000001)
Ala Gln Tyr Trp
C28H34N6O7 (566.2488854000001)
Ala Trp Gln Tyr
C28H34N6O7 (566.2488854000001)
Ala Trp Tyr Gln
C28H34N6O7 (566.2488854000001)
Ala Tyr Gln Trp
C28H34N6O7 (566.2488854000001)
Ala Tyr Trp Gln
C28H34N6O7 (566.2488854000001)
Cys Cys Arg Trp
C23H34N8O5S2 (566.2093474000001)
Cys Cys Trp Arg
C23H34N8O5S2 (566.2093474000001)
Cys Lys Met Trp
Cys Lys Trp Met
Cys Met Lys Trp
Cys Met Gln Trp
Cys Met Trp Lys
Cys Met Trp Gln
Cys Gln Met Trp
Cys Gln Trp Met
Cys Arg Cys Trp
C23H34N8O5S2 (566.2093474000001)
Cys Arg Trp Cys
C23H34N8O5S2 (566.2093474000001)
Cys Trp Cys Arg
C23H34N8O5S2 (566.2093474000001)
Cys Trp Lys Met
Cys Trp Met Lys
Cys Trp Met Gln
Cys Trp Gln Met
Cys Trp Arg Cys
C23H34N8O5S2 (566.2093474000001)
Asp Asn Arg Tyr
Asp Asn Tyr Arg
Asp Arg Asn Tyr
Asp Arg Tyr Asn
Asp Tyr Asn Arg
Asp Tyr Arg Asn
Glu Gln Gln Tyr
Glu Gln Tyr Gln
Glu Tyr Gln Gln
Phe His Thr Tyr
C28H34N6O7 (566.2488854000001)
Phe His Tyr Thr
C28H34N6O7 (566.2488854000001)
Phe Asn Thr Trp
C28H34N6O7 (566.2488854000001)
Phe Asn Trp Thr
C28H34N6O7 (566.2488854000001)
Phe Gln Ser Trp
C28H34N6O7 (566.2488854000001)
Phe Gln Trp Ser
C28H34N6O7 (566.2488854000001)
Phe Ser Gln Trp
C28H34N6O7 (566.2488854000001)
Phe Ser Trp Gln
C28H34N6O7 (566.2488854000001)
Phe Thr His Tyr
C28H34N6O7 (566.2488854000001)
Phe Thr Asn Trp
C28H34N6O7 (566.2488854000001)
Phe Thr Trp Asn
C28H34N6O7 (566.2488854000001)
Phe Thr Tyr His
C28H34N6O7 (566.2488854000001)
Phe Trp Asn Thr
C28H34N6O7 (566.2488854000001)
Phe Trp Gln Ser
C28H34N6O7 (566.2488854000001)
Phe Trp Ser Gln
C28H34N6O7 (566.2488854000001)
Phe Trp Thr Asn
C28H34N6O7 (566.2488854000001)
Phe Tyr His Thr
C28H34N6O7 (566.2488854000001)
Phe Tyr Thr His
C28H34N6O7 (566.2488854000001)
His Phe Thr Tyr
C28H34N6O7 (566.2488854000001)
His Phe Tyr Thr
C28H34N6O7 (566.2488854000001)
His His His His
C24H30N12O5 (566.2462009999999)
His Thr Phe Tyr
C28H34N6O7 (566.2488854000001)
His Thr Tyr Phe
C28H34N6O7 (566.2488854000001)
His Tyr Phe Thr
C28H34N6O7 (566.2488854000001)
His Tyr Thr Phe
C28H34N6O7 (566.2488854000001)
Lys Cys Met Trp
Lys Cys Trp Met
Lys Met Cys Trp
Lys Met Trp Cys
Lys Trp Cys Met
Lys Trp Met Cys
Met Cys Lys Trp
Met Cys Gln Trp
Met Cys Trp Lys
Met Cys Trp Gln
Met Lys Cys Trp
Met Lys Trp Cys
Met Gln Cys Trp
Met Gln Trp Cys
Met Trp Cys Lys
Met Trp Cys Gln
Met Trp Lys Cys
Met Trp Gln Cys
Asn Asp Arg Tyr
Asn Asp Tyr Arg
Asn Phe Thr Trp
C28H34N6O7 (566.2488854000001)
Asn Phe Trp Thr
C28H34N6O7 (566.2488854000001)
Asn Arg Asp Tyr
Asn Arg Tyr Asp
Asn Thr Phe Trp
C28H34N6O7 (566.2488854000001)
Asn Thr Trp Phe
C28H34N6O7 (566.2488854000001)
Asn Trp Phe Thr
C28H34N6O7 (566.2488854000001)
Asn Trp Thr Phe
C28H34N6O7 (566.2488854000001)
Gln Ala Trp Tyr
C28H34N6O7 (566.2488854000001)
Gln Ala Tyr Trp
C28H34N6O7 (566.2488854000001)
Gln Cys Met Trp
Gln Cys Trp Met
Gln Glu Gln Tyr
Gln Glu Tyr Gln
Gln Phe Ser Trp
C28H34N6O7 (566.2488854000001)
Gln Phe Trp Ser
C28H34N6O7 (566.2488854000001)
Gln Met Cys Trp
Gln Met Trp Cys
Gln Gln Glu Tyr
Gln Gln Tyr Glu
Gln Ser Phe Trp
C28H34N6O7 (566.2488854000001)
Gln Ser Trp Phe
C28H34N6O7 (566.2488854000001)
Gln Trp Ala Tyr
C28H34N6O7 (566.2488854000001)
Gln Trp Cys Met
Gln Trp Phe Ser
C28H34N6O7 (566.2488854000001)
Gln Trp Met Cys
Gln Trp Ser Phe
C28H34N6O7 (566.2488854000001)
Gln Trp Tyr Ala
C28H34N6O7 (566.2488854000001)
Gln Tyr Ala Trp
C28H34N6O7 (566.2488854000001)
Gln Tyr Glu Gln
Gln Tyr Gln Glu
Gln Tyr Trp Ala
C28H34N6O7 (566.2488854000001)
Arg Cys Cys Trp
C23H34N8O5S2 (566.2093474000001)
Arg Cys Trp Cys
C23H34N8O5S2 (566.2093474000001)
Arg Asp Asn Tyr
Arg Asp Tyr Asn
Arg Asn Asp Tyr
Arg Asn Tyr Asp
Arg Trp Cys Cys
C23H34N8O5S2 (566.2093474000001)
Arg Tyr Asp Asn
Arg Tyr Asn Asp
Ser Phe Gln Trp
C28H34N6O7 (566.2488854000001)
Ser Phe Trp Gln
C28H34N6O7 (566.2488854000001)
Ser Gln Phe Trp
C28H34N6O7 (566.2488854000001)
Ser Gln Trp Phe
C28H34N6O7 (566.2488854000001)
Ser Trp Phe Gln
C28H34N6O7 (566.2488854000001)
Ser Trp Gln Phe
C28H34N6O7 (566.2488854000001)
Thr Phe His Tyr
C28H34N6O7 (566.2488854000001)
Thr Phe Asn Trp
C28H34N6O7 (566.2488854000001)
Thr Phe Trp Asn
C28H34N6O7 (566.2488854000001)
Thr Phe Tyr His
C28H34N6O7 (566.2488854000001)
Thr His Phe Tyr
C28H34N6O7 (566.2488854000001)
Thr His Tyr Phe
C28H34N6O7 (566.2488854000001)
Thr Asn Phe Trp
C28H34N6O7 (566.2488854000001)
Thr Asn Trp Phe
C28H34N6O7 (566.2488854000001)
Thr Trp Phe Asn
C28H34N6O7 (566.2488854000001)
Thr Trp Asn Phe
C28H34N6O7 (566.2488854000001)
Thr Tyr Phe His
C28H34N6O7 (566.2488854000001)
Thr Tyr His Phe
C28H34N6O7 (566.2488854000001)
Trp Ala Gln Tyr
C28H34N6O7 (566.2488854000001)
Trp Ala Tyr Gln
C28H34N6O7 (566.2488854000001)
Trp Cys Cys Arg
C23H34N8O5S2 (566.2093474000001)
Trp Cys Lys Met
Trp Cys Met Lys
Trp Cys Met Gln
Trp Cys Gln Met
Trp Cys Arg Cys
C23H34N8O5S2 (566.2093474000001)
Trp Phe Asn Thr
C28H34N6O7 (566.2488854000001)
Trp Phe Gln Ser
C28H34N6O7 (566.2488854000001)
Trp Phe Ser Gln
C28H34N6O7 (566.2488854000001)
Trp Phe Thr Asn
C28H34N6O7 (566.2488854000001)
Trp Lys Cys Met
Trp Lys Met Cys
Trp Met Cys Lys
Trp Met Cys Gln
Trp Met Lys Cys
Trp Met Gln Cys
Trp Asn Phe Thr
C28H34N6O7 (566.2488854000001)
Trp Asn Thr Phe
C28H34N6O7 (566.2488854000001)
Trp Gln Ala Tyr
C28H34N6O7 (566.2488854000001)
Trp Gln Cys Met
Trp Gln Phe Ser
C28H34N6O7 (566.2488854000001)
Trp Gln Met Cys
Trp Gln Ser Phe
C28H34N6O7 (566.2488854000001)
Trp Gln Tyr Ala
C28H34N6O7 (566.2488854000001)
Trp Arg Cys Cys
C23H34N8O5S2 (566.2093474000001)
Trp Ser Phe Gln
C28H34N6O7 (566.2488854000001)
Trp Ser Gln Phe
C28H34N6O7 (566.2488854000001)
Trp Thr Phe Asn
C28H34N6O7 (566.2488854000001)
Trp Thr Asn Phe
C28H34N6O7 (566.2488854000001)
Trp Tyr Ala Gln
C28H34N6O7 (566.2488854000001)
Trp Tyr Gln Ala
C28H34N6O7 (566.2488854000001)
Tyr Ala Gln Trp
C28H34N6O7 (566.2488854000001)
Tyr Ala Trp Gln
C28H34N6O7 (566.2488854000001)
Tyr Asp Asn Arg
Tyr Asp Arg Asn
Tyr Glu Gln Gln
Tyr Phe His Thr
C28H34N6O7 (566.2488854000001)
Tyr Phe Thr His
C28H34N6O7 (566.2488854000001)
Tyr His Phe Thr
C28H34N6O7 (566.2488854000001)
Tyr His Thr Phe
C28H34N6O7 (566.2488854000001)
Tyr Asn Asp Arg
Tyr Asn Arg Asp
Tyr Gln Ala Trp
C28H34N6O7 (566.2488854000001)
Tyr Gln Glu Gln
Tyr Gln Gln Glu
Tyr Gln Trp Ala
C28H34N6O7 (566.2488854000001)
Tyr Arg Asp Asn
Tyr Arg Asn Asp
Tyr Thr Phe His
C28H34N6O7 (566.2488854000001)
Tyr Thr His Phe
C28H34N6O7 (566.2488854000001)
Tyr Trp Ala Gln
C28H34N6O7 (566.2488854000001)
Tyr Trp Gln Ala
C28H34N6O7 (566.2488854000001)
5'-Hydroxycastavinol
Cassiaside B
Mulberroside F
Cediranib maleate
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
2-[(1E,3E)-5-(3,3-DIMETHYL-1-PROPYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-3,3-DIMETHYL-1-PROPYL-3H-INDOLIUM IODIDE
ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
2-(2-Chloro-5-(((2S)-3-(5-chloro-2,3-dihydrospiro(benzofuran-2,4-piperidin)-1-yl)-2-hydroxypropyl)oxy)-4-((methylamino)carbonyl)phenoxy)-2-methylpropanoic acid
1-{[4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazol-1-YL]carbonyl}piperazine
Prednisolone sodium metazoate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(4aS,5S,12aS)-2-carbamoyl-6-[(2E)-3,7-dimethylocta-2,6-dienyl]-4a,5,10,11,12a-pentahydroxy-8-methoxy-3,12-dioxo-4,5-dihydrotetracen-1-olate
Dehydrodiconiferyl dibenzoate
A lignan that is 2,3-dihydro-1-benzofuran substituted by a (benzoyloxy)methyl group at position 3, a 4-hydroxy-3-methoxyphenyl group at position 2, a methoxy group at position 7 and a 3-(benzoyloxy)prop-1-en-1-yl group at position 5. It is isolated as a racemate from Euterpe precatoria and exhibits antiplasmodial activity.
4-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists
Meclorisone dibutyrate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
N-[3-(dimethylamino)propyl]-N-(4-ethoxy-1,3-benzothiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide
C29H34N4O4S2 (566.2021364000001)
N-[3-(dimethylamino)propyl]-N-([1,3]dioxolo[4,5-f][1,3]benzothiazol-6-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide
4-fluoro-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
1-[[(2S,3S)-10-[(4-chlorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C26H35ClN4O6S (566.1965720000001)
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
4-fluoro-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-8-(3-methoxyprop-1-ynyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide
1-[[(2S,3S)-10-[(4-chlorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C26H35ClN4O6S (566.1965720000001)
4-fluoro-N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylbenzenesulfonamide
1-[[(2R,3R)-10-[(4-chlorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C26H35ClN4O6S (566.1965720000001)
1-[[(2R,3S)-10-[(4-chlorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C26H35ClN4O6S (566.1965720000001)
1-[[(2R,3R)-10-[(4-chlorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C26H35ClN4O6S (566.1965720000001)
1-[[(2R,3S)-10-[(4-chlorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
C26H35ClN4O6S (566.1965720000001)
(E)-1-[4-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-2-hydroxyphenyl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one
6-[[10-Butanoyl-3-hydroxy-6-(2-hydroxypropyl)-2,2-dimethyl-8-oxo-3,4-dihydropyrano[3,2-g]chromen-5-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[[3-hydroxy-10-(3-hydroxybutanoyl)-2,2-dimethyl-8-oxo-6-propyl-3,4-dihydropyrano[3,2-g]chromen-5-yl]oxy]oxane-2-carboxylic acid
5-[(E)-2-[(2S,3R,4S)-5-carboxy-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]ethenyl]-1-(3-carboxypropyl)pyridin-1-ium-3-carboxylic acid
C26H32NO13+ (566.1873562000001)
[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C25H43O12P (566.2492007999999)